跳至主要内容
临床试验/TCTR20160215001
TCTR20160215001尚未招募未知

The study of outcome, quality of life and cost-effectiveness in glaucoma patients receiving trabeculectomy versus medication

็Health systems research institute0 个研究点目标入组 118 人开始时间: 2016年2月15日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
118

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Newly diagnosed (within 3 months) glaucoma which is one of the followings: primary open angle glaucoma or pseudo exfoliation glaucoma or primary angle closure glaucoma that was underwent laser iridotomy and had visible trabecular meshwork at least 180 degrees.
  • 2. Initial intraocular pressure at least 20 mmHg
  • 3. Visual field mean deviation less than -6 dB
  • 4. Able to have regular follow up schedule

排除标准

  • 1. history of any intraocular surgery except for uncomplicated phacoemulsification with IOL for more than 3 months.
  • 2. active intraocular inflammation
  • 3. history of eye trauma
  • 4. current or anticipated (in 1 year) pregnancy
  • 5. allergy to sulfonamide
  • 6. uncooperated patient

研究者

发起方
็Health systems research institute

相似试验